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Abstract
Background: Lymphatic filariasis (LF), a neglected tropical disease (NTD) and leading cause of global disability, is
endemic in 32 countries in Africa with almost 350 million people requiring regular drug administration, and only 16
countries achieving target coverage. Community Drug Distributors (CDDs) are critical for the success of NTD
programs, and the distribution of medicines during mass drug administration (MDA) in Africa; however they could
also be a weak link. The primary aim of this study is to explore and describe perceptions of CDDs during MDA for
LF in Mvita sub-county in Mombasa county and Kaloleni sub-county in Kilifi county, Kenya; and provide
recommendations for the effective engagement of communities and CDDs in low-resource settings.
Methods: In September 2018, we conducted six focus group discussions with community members in each
sub-county, three with men aged 18–30, 31–50, and 51 years and above and three with women stratified into
the same age groups. In each sub-county, we also conducted semi-structured interviews with nine community health
extension workers (CHEWs), the national LF focal point, the county NTD focal points, and seven community leaders.
Content analysis of the data was conducted, involving a process of reading, coding, and displaying data in order to
develop a codebook.
Results: We found that several barriers and facilitators impact the engagement between CDDs and community
members during MDA. These barriers include poor communication and trust between CDDs and communities;
community distrust of the federal government; low community knowledge and perceived risk of LF, poor timing
of MDA, fragmented supervision of CDDs during MDA; and CDD bias when distributing medicines. We also found
that CDD motivation was a critical factor in their ability to successfully meet MDA targets. It was acknowledged
that directly observed treatment and adequate health education were often not executed by CDDs. The
involvement of community leaders as informal supervisors of CDDs and community members improves MDA.
Conclusions: In order to achieve global targets around the elimination of LF, CDDs and communities must be
effectively engaged by improving planning and implementation of MDA.
Keywords: Neglected tropical diseases, Lymphatic filariasis, Mass drug administration, Community drug distributors,
Preventive chemotherapy, Qualitative methods, Community health, Health service
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Background
Neglected Tropical Diseases (NTDs) affect more than 2 bil-
lion people around the world, causing disability and death in
vulnerable populations [1]. Thirty-two of the 52 countries
that require preventive chemotherapy are in Africa, and al-
most 350 million people in Africa require regular drug
administration. Only 16 countries in Africa achieved target
coverage [2]. LF is one of five NTDs whose transmission
cycle can be interrupted through annual large-scale distribu-
tion or mass drug administration (MDA) of preventive
chemotherapy. In Africa, MDA campaigns usually rely on
community drug distributors (CDDs).
Today, CDDs are critical for the success of many NTD
programs, and the achievement of current global targets
for the elimination of diseases like LF and onchocercia-
sis; however they could also be a weak link [3, 4]. Studies
conducted in several African countries have shown the
factors that jeopardize the sustainability and success of
community-directed treatment programs, as well as the
barriers and facilitators of coverage and compliance, in-
cluding the motivation and performance of CDDs. A
study profiling the best performing CDDs in Uganda
demonstrated that treatment rates were associated with
CDD characteristics rather than the willingness of com-
munity members to comply with treatment [5]. In some
contexts, the selection and recruitment of CDDs are not
led by the community or made transparent, resulting in
community resistance and lack of trust of CDDs [6, 7].
A study conducted in Ethiopia found that CDDs had
poor knowledge, attitude and practices related to on-
chocerciasis, leading to low participation of commu-
nity members in MDA [8]. In Tanzania and Nigeria,
researchers showed that CDDs did not understand
the cause and transmission of the disease due to in-
adequate trainings. As a result, CDDs passed on
wrong information to community members about LF,
impacting community trust of CDDs [6, 9]. Also,
CDDs in Northern Nigeria did not understand how
to engage with individuals with physical disabilities
and other complex conditions due to inconsistencies
in messages during trainings [9].
Community drug distributors’ preferences for financial
and material incentives, and their effect on motivation,
are important factors in the implementation of MDA
campaigns. In a study conducted in Uganda, Fleming
and colleagues found that CDDs were driven by both in-
trinsic and extrinsic motivations. They were motivated
to serve their communities and gain recognition; and
also desired financial and material incentives, such as T-
shirts, bags, hats, boots and waterproof coats with the
program logo and certificates [10]. They also felt that
financial compensation should reflect out of pocket ex-
penses and opportunity costs incurred during MDA
[10]. Opportunity costs can include missing out on
farming and other small-scale ventures, as well as house-
hold food and school costs [10, 11]. In Ghana and
Nigeria, CDDs preferred certificates, T-shirts, bicycles,
ID cards, hats, preferential treatment at the district hos-
pitals or health centres as compensation for their work
[9, 11].
CDDs have reported that the support given by com-
munities and the NTD program is not enough motiv-
ation [9, 10]. In Nigeria, Kenya and Ghana, CDDs
expressed a desire to see their supervisors throughout
MDA in order to increase their confidence and promote
community acceptance of MDA [7, 9, 11]. The lack of
supportive supervision of CDDs is often due to the high
workload of supervisors during MDA campaigns and the
provision of routine health services within healthcare
centres [6, 11]. In Cameroon, CDDs working in the on-
chocerciasis program reported that low appreciation and
community support affected their motivation [12]. Fur-
thermore, in Nigeria, positive feedback from communi-
ties was a major motivating factor, resulting in feelings
of happiness and fulfilment for CDDs. Also, supervisors
and CDDs wanted more feedback and appreciation from
the health sector, and to be acknowledged as contribu-
tors to population health [9].
In addition, CDDs’ workload during MDA also im-
pacts their motivation and performance. In Tanzania,
CDDs mentioned that they did not receive adequate
time in order to achieve their performance goals [6]. In
Nigeria, high attrition among CDDs resulted in high
workload for the remaining CDDs, resulting in low mo-
tivation and disengagement [9]. In India and Ghana,
CDDs reported difficulties with being able to deliver
medicines in the time frame they were allotted [11, 13].
In efforts to achieve performance targets, CDDs are not
compensated for the extra time they use to distribute
medicines [6].
Furthermore, CDDs have reported a lack of re-
sources and medicines to be able to perform well
during MDA. In Uganda and Nigeria, researchers
found that drug stock outs due to inaccurate census,
insufficient transportation, bags to carry program doc-
uments, clean water for ingesting medicines, and in-
sufficient quantities of registers and measuring sticks
impacted the on-the-job experiences of CDDs [9, 10].
The inability to properly store and dispense tablets,
and offer communities treatment for drug side effects
also hinder CDDs’ work [10, 14].
Although studies have contributed to our understand-
ing of the many challenges that demotivate and disen-
gage CDDs and communities, additional evidence is
needed to identify pathways for improving and sustain-
ing the motivation of CDDs and engagement of commu-
nities. A systematic review of the factors influencing the
motivation of CDDs concluded that there is a need for
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more research on measures that improve CDD motiv-
ation within the context of the local health system and
changing sociocultural environment [15]. The investiga-
tion of the perceptions of CDDs can reveal the measures
and pathways needed to better equip and engage CDDs.
The Kenyan context
Evidence for the engagement of CDDs for the elimination
of LF in Kenya is limited. Findings from studies conducted
over five years ago in Kenya indicate that lack of supervi-
sion, lack of community trust in CDDs, inadequate train-
ing for CDDs and CDDs’ inability to reach households
resulted in low coverage and compliance [7, 16]. Given
the changing socio-cultural and economic landscape of
countries like Kenya, and recent efforts to deliver multiple
combinations of medicines to accelerate the elimination of
LF, there are added pressures on CDDs to not only meet
the demands of the NTD program, but also those of their
families and communities. The NTD community needs a
better understanding of how the roles, perceptions and
job experiences of CDDs have changed in Kenya amidst
new and intensified global, national, sub-national commit-
ments and agendas. This new understanding can inform
the development and implementation of recommenda-
tions, and ensure that no one is left behind.
Methods
Research design
This qualitative study used semi-structured key informant
interviews and focus group discussions. Semi-structured
interviews were conducted with community leaders, com-
munity health extension workers (CHEWs), and NTD
program officials at the county and national levels.
CHEWs are formally trained health care workers respon-
sible for supervising CDDs during MDA. Focus group dis-
cussions were conducted with community members. The
aim of these interviews was to explore the perception of
CDDs during MDA.
Setting
The study was conducted in September 2018 in coastal
Kenya in Mvita sub-county, an urban area in Mombasa
county, and Kaloleni sub-county in a rural area in Kilifi
county. Two sites with coverage below the treatment
threshold of greater than or equal to 65% in the two
MDA rounds preceding this study were selected to com-
pare differences and similarities in perceptions of CDDs.
In 2015 and 2016, Kaloleni sub-county achieved cover-
age of 61 and 58% respectively, and in 2016 and 2017,
Mvita sub-county achieved coverage of 51 and 59%
respectively.
Data collection
Focus groups
We conducted six focus group discussions with commu-
nity members in each sub-county. Three focus groups
were conducted with men aged 18–30, 31–50, and 51
years and above and another three with women stratified
into the same age groups. We hypothesized that there
may be differences in perspectives by stratum. The sub-
county NTD focal point worked with community leaders
to purposively select participants for the focus group dis-
cussions. Community leaders were asked by the focal
point to contact individuals that resided in the commu-
nity, present at the time of the study and most recent
MDA, were over the age of 18, and were willing to come
to a specified location and time the following day for an
interview. The first 48 individuals to answer leaders’ calls
and agree to participate were included in the study as
participants. Community leaders informed participants
about the location, day, and time of the interviews. In
each sub-county, two trained public health interns from
nearby health facilities moderated the focus group dis-
cussions, with one moderator assuming the role of note
taker. The total number of participants in each focus
group was eight. The focus group discussions were con-
ducted in a private room, at either the railway dispensary
or sub county health center. The venues were chosen
based on the convenience for the participants. The dis-
cussions were conducted in KiSwahili, the national lan-
guage of Kenya, and lasted for approximately 75 min. A
topic guide was used to facilitate discussions.
Semi-structured interviews
In each sub-county, nine CHEWs and seven commu-
nity leaders were purposively selected and inter-
viewed. The county NTD and national LF focal points
were also interviewed. Participants were identified and
recruited by a sub-county NTD program official, and
were 18 years of age and above and participated in
the most recent MDA. In each sub-county, two
trained public health interns from nearby health facil-
ities conducted the interviews. The interviews took
place in a private room at the closest health centre or
in the participant’s home, and lasted for approxi-
mately 60 min. The interviews, conducted in
KiSwahili, explored a range of topics related to CDDs
and community experiences during MDA.
Quality control
In order to ensure data quality and optimization,
interview guides were translated from English to Ki-
Swahili and KiSwahili to English in order to reconcile
discrepancies and differences. One of the authors and
a senior research assistant that spoke KiSwahili super-
vised all interviewers to ensure that interviewing and
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data capture techniques were adhered to. After inter-
views, interviewers reviewed and added to their notes,
and uploaded recordings to the cloud. Interviewers
transcribed recordings into English at the end of each
day. The senior research assistant randomly selected
two recordings and transcripts from each interviewer
to ensure consistency between recording and
transcription.
Data analysis
Interviews with forty-eight focus group participants,
eight CHEWs and six community leaders in each
sub-county were digitally recorded and transcribed
verbatim. Transcripts were translated to English,
reviewed, and then manually coded. Content analysis
of the data was conducted (Young Cho & Lee, 2014),
which involved a process of reading, coding, and dis-
playing data in order to develop a codebook. Mem-
bers of the study team read a subset of transcripts
and coded emerging themes, reviewed coding, and re-
fined the codebook through an iterative process until
consensus was reached between the authors. In order
to reach consensus, analyses, codes and themes on
the same text were compared to examine similarities
and differences. Where there were differences, we ac-
tively re-read the text and discussed perspectives. This
iterative process consisted of the integration of both
deductive and inductive methods to identify predeter-
mined and emergent themes (Young Cho & Lee,
2014). Predetermined themes were based on the study
objectives, and included community engagement with
CDDs, NTD program engagement with CDDs and
CDD motivation and remuneration.
Ethical considerations
Informed consent was obtained from all study partici-
pants, including consent to digitally record interviews.
This study was reviewed and approved by the Kenya
Medical Research Institute Scientific and Ethics Review
Unit, and a waiver was obtained from the Ethics Com-
mittee of Northwest and Central Switzerland, approval
number 2018–00694.
Results
A total of 10 themes emerged from the data (Table 1).
They are classified into three groups: themes, sub-
themes, and perspectives. Sub-themes and perspectives
did not differ by age and gender.
Focus group discussions
Participants shared that LF is caused by mosquitoes,
and manifests as swelling of legs, scrotum and
breasts. They also expressed that LF can be controlled
with drugs and using mosquito nets at home. The
reasons cited for risk of LF included poor waster dis-
posal, being near the ocean and the presence of mos-
quitoes. Only one focus group participant reported
that worms caused LF. Perception of risk for LF was
high among focus group participants. Acceptance of
LF medication during the last MDA varied among the
groups. There were some observed differences by age
and gender among those that reporting having taken
the drugs and those that did not.
Semi-structured interviews
In each sub-county, five out of six community leaders
reported incomplete primary school education, and all
CHEWs had at least a secondary school degree. Most
participants identified themselves as Muslim.
Communication with CDDs
Some participants indicated that lack of knowledge of
LF and MDA made it difficult for them to accept CDDs
and the medication. Mainly, they expressed a lack of ef-
fective communication with CDDs influenced their deci-
sion to accept medicines. In addition, CDDs are often in
a hurry and don’t provide adequate explanations about
medicines.
Some have bad approach to the community. Some
are in hurry and therefore don’t explain the usage of
drug and why are people being given drugs. (FGD,
men, 30–50 years old)
Some CDDs teach us in a way we don’t get to under-
stand the message. Some people are slow learners.
(FGD, women, 50 years and above)
Qualities of a good CDD
When participants discussed qualities of a good CDD
and how CDDs were selected, they consistently reported
the importance of CDDs’ relationship with the commu-
nity. Focus group discussions and interviews with CDDs
and community leaders revealed that CDDs that were
from the community or those that were well known
among community members were trusted and accepted.
Furthermore, participants described how a trusting rela-
tionship between the community and CDD made it less
challenging for CDDs to gain access to the households
to distribute medicines.
The community give me positive feedback about
them, they say that they are respectful and they
interact well with them. Their relationship is good
because they all come from the same community
and have a good understanding with each other.
The community is welcoming to them because they
know each other. (Elder, woman, 63 years old)
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On the other hand, CDDs that are not selected by
community members will not be given the opportunity
to distribute medicines because they are not trusted.
… We have never seen them in the community that’s
why it’s hard for some to accept the drugs. I would
trust someone from within the community more than
strangers. (FGD, women, 18–30 years old)
Participants mentioned that CDDs were chosen to vol-
unteer for MDA based on their relationship with the
community, work history, and ability to perform the job
tasks (e.g. climbing tall buildings). Several participants
suggested that CDDs that were well mannered, respect-
ful, trustworthy, and had a good reputation were well re-
ceived by the community. Participants also mentioned
that patience was an important quality for CDDs to pos-
sess because they endured a great deal of resistance from
the community.
Like I told you, we don’t choose people if they have a
bad image, unless that person has good relations
Table 1 Perceptions of CDDs
Themes Sub-Themes Perspectives
Communication
between CDDs and
the community
CDDs hurriedly distribute drugs, resulting in little to no
health education.
Adequate health education enables community members to
understand LF as a disease with devastating outcomes. Once
this is understood from CDDs, they are more likely to
participate in MDA and ingest medicines.
Qualities of good
CDDs
Trust is established between CDDs and communities when
CDDs are nominated and selected by their community.
CDDs that are perceived to behave well and have a good
image are desirable.
When trust is established, CDD interactions with community
members are positive. As a result, community members are
able to trust information from CDDs about the importance of
MDA and ingesting medicines. Conversely, when CDDs are
not trusted, community members are hostile and refuse
medicines. CDDs must be known and selected by their
community in order to achieve their goals during MDA.
CDDs that are not only selected by community members, but
are also well mannered and respectful are embraced and
trusted.
Community resistance
toward CDDs
Community members’ distrust of CDDs often led to sharp
resistance and negative treatment of CDDs.
Drug misconceptions stemming from cultural beliefs, political
propaganda, and lack of awareness fuel resistance to MDA
and CDDs in the community.
Community distrust of
the federal
government
Community members perceive that the government is
motivated by a political agenda, and that MDA is the
platform used to advance their harmful agenda.
Community members perceive MDA to be a way for the
government of Kenya to enforce family planning. This
misinformation results in a lack of participation in MDA.
CDD motivation Community members perceive that CDDs are motivated
when they feel appreciated by them.
When communities are receptive to the health information,
look for CDDs to obtain the drugs, encourage their neighbors
to accept the drugs, and provide water, airtime and food,
CDDs often feel appreciated. Monetary incentives also serve
as motivation for some CDDs to perform well, especially
those who are unemployed. Nonetheless, the primary
motivator for volunteering among CDDs is their commitment
to serve the community.
Perception of MDA as
a distribution strategy
Community members that perceive that drugs should be
distributed in private facilities or hospitals often don’t
participate in MDA and belong the higher income groups.
On the other hand, those in the lower income groups
embrace MDA.
CDDs find it challenging to reach those in higher income
levels because they perceive that access to medicines should
be from private doctors and hospitals in the event that they
do fall sick. This perception may suggest that LF is a disease
associated with poverty and that CDDs are not qualified to
offer them medicines.
Timing of MDA The period during which CDDs distributed medicines has an
impact on coverage.
Some community members are frequently absent during
MDA because of work, travel or school.
Community
accountability during
MDA
Community elders often help achieve treatment coverage
through indirect supervision of community members and
CDDs during MDA.
Community leaders serve as informal supervisors by
addressing troublesome community members and by
encouraging them to accept and ingest medicines.
CDD bias CDDs purposively decide which individuals and groups
would receive medicines, which impacts treatment coverage.
Community members believe that CDDs should offer drugs
to everyone and not those they like.
Community
understanding of
CDD job
responsibilities
CDDs are expected to engage in a variety of activities before,
during and after MDA.
Directly observed treatment, health education prior to MDA,
dosage assessment, and mop-up are all responsibilities of
CDDs. Community members report forgetting to take the
drugs when CDDs left the drugs, without implementing dir-
ectly observed treatment.
CDDs Community drug distributors; LF Lymphatic filariasis; MDA Mass drug administration.
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with the community that’s when our work also be-
comes easier because already there is a connection.
If a CDD is not respectful then there wouldn’t be a
good relationship. (Elder, man, 54 years old)
Community resistance toward CDDs
Over 20 interview participants expressed the view that
CDDs endured harsh treatment from community mem-
bers during drug distribution. Experiences of harsh
treatment included being chased away, having doors
slammed in their faces, and encountering insults.
You know people can’t be the same, sometimes a CDD
could knock at the door but they don’t open or when
they open they become harsh, abusive and bang the
door at your face. (Elder, woman, 64 years old)
Community distrust of government
The most common drug misconceptions reported by
participants included that drugs were not safe and
intended for promoting family planning.
Many people have lost trust with CDDs because
some think its political, there is some registration
that goes on before the MDA, people think it is con-
nected to politics that there may be rigging of elec-
tions. Some believe it’s a way that the government is
using to reduce the population, a way of family
planning. (FGD, women 50 years old and above)
There is a challenge because you know there is the
rich, poor and middle class. The rich have problems,
they have the attitude that they are being given fam-
ily planning drugs, not opening the doors or if they
do, then they insult you. (CHEW, two years of
experience)
Perception of MDA as a distribution strategy
Participants also mentioned that some community mem-
bers, primarily the higher class, did not accept the drugs
because they prefer to be treated in a hospital or by their
own private doctors.
Some people chase the CDDs away saying they have
their own private doctors that they can go to in case
of any medication. (Elder, man, 50 years old)
It depends on the community, you find that some of
these people that are in the middle and high-income
level, feel that MDA is beneath them. They feel that
they can access better services in private facilities,
but you find that in the informal sectors and low in-
come earners, they embrace the MDA in fact they
ask for the medicines. So there is always this dispar-
ity between the high and low-income earners.
(CHEW, two years of experience)
CDD motivation
Elders and community members shared that they be-
lieved that CDDs were more motivated when they felt
appreciated and supported by the community. They also
felt that CDDs appreciated it when community members
received them well, were receptive to the health infor-
mation, and accepted the medication. Participants also
shared the view that CDDs felt appreciated when com-
munity members looked for them to obtain the drugs, as
well as encouraged their neighbours to accept the drugs.
Several participants described instances when commu-
nity members expressed gratitude and provided CDDs
with resources such as water, food, and airtime.
In some households they express their appreciation
by providing water, milk or refreshments considering
the fact that they are not provided these things dur-
ing the MDA is something positive for them. (Elder,
man, 50 years old)
Yes I feel they are rewarded and appreciated be-
cause we listen to what they have to tell us and
accept what they have to offer. We also respect them
for that. (FGD, women 18–30 years old)
Community members and leaders indicated that ex-
trinsic rewards, especially the monetary incentive, served
as a significant motivator for CDDs.
Some CDDs do the job as a source of income, so
their motivation is the money they get after the
job. So many of us are unemployed. (FGD, women,
18–30 years old)
Community level accountability
Some participants suggested that community leaders
served as informal supervisors. Community leaders ac-
companied CDDs in the field and ensured they per-
formed their duties. Several participants also described
how community leaders assisted CDDs when they faced
resistance in the field. Community leaders were crucial
in helping CDDs gain the trust of the community.
Participants also discussed how community leaders sup-
ported CDDs by helping to dispel misconceptions about
the drugs and assisting with difficult community
members.
Other people refuse the drugs when given by other
CDDs unless they see me. When I show up they calm
down and accept. (Elder, woman, 64 years old)
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Incitement among the community members, some
spreading negative news about the medicines
that’s why village elders are involved to convince
the community that the stories are not true. They
believe in us even more than the sister or nurse
accompanying us because they don’t have enough
interaction with the community. (Elder, man, 50
years old)
Timing of MDA
Focus group and interview participants discussed the
issue of participants not being available during MDA.
The reasons for community members’ unavailability dur-
ing the MDA included work, school, and travel. This re-
sulted in low coverage, especially when CDDs did not
return to the household.
The problem was time factor they want to distribute
the drugs during the day and that is the time when
most people are at work. Supposed they were doing
it at night, when we are all at home in the evening
or at night then all of use would have taken medi-
cines. (FGD, men, 30–50 years old)
CDD bias
For focus group participants, some CDDs are biased
when distributing drugs so that community members
are not offered the medicines.
They should be able to give drugs to all not denying
others. (FGD, men 30–50 years old)
Community knowledge of CDD job responsibilities
The majority of participants mentioned that CDDs
were expected to distribute drugs door to door, pro-
vide education on LF and the importance of drugs,
and administer the proper dosage. Several participants
expressed that CDDs were expected to perform
directly observed treatment, without force, and to fol-
low up with missed clients to ensure all households
are met.
Before the MDA, the CDDs come to inform us after
which they distribute the drugs. After the MDA, I see the
CDDs coming around to check on those who had missed
out on the drugs. (FGD, women, 18–30 years old)
Participants pointed out that some CDDs left the
drugs for household members that are not around at
the time of distribution or allowed household mem-
bers to ingest the drugs later. Several focus group
participants reported that some community members
did not take the drugs because they forgot to take
them later or they disposed of them instead.
“You see some CDDs bring the medicine but do not
wait to watch someone swallow. They just give and
go so in that case they don’t swallow. (FGD, women
30–50 years old)
Interviews with the national LF focal point and county
NTD focal points revealed similar themes around bar-
riers and facilitators of implementing successful MDA
campaigns. First, the program’s limited financial re-
sources for MDA lead to inadequate pay for CDDs, as
well as high workload given the limited number of days
allocated for MDA. In addition, treatment coverage is
often affected by individuals’ strong cultural and
religious beliefs around LF and the purpose of the medi-
cations. For example, Muslim husbands might prevent
their wives from ingesting drugs because of their fear it
may result in infertility. Furthermore, perceptions
around the causes of LF are informed by cultural beliefs
passed on from generation to generation, making it diffi-
cult for some communities to participate in MDA. Given
Kenya’s political challenges over the last decade, many
communities have a deep lack of trust for government
programs and initiatives. The focal points agreed that
more resources are needed to better educate communi-
ties about LF, gain the support of community leaders,
develop additional fixed posts for distribution of med-
icines, improve supervision of CDDs, access hard-to-
reach areas, and motivate CDDs to achieve their
MDA targets.
Discussion
The current study systematically examines perceptions
of CDDs from the perspectives of multiple stakeholders
in coastal Kenya. The use of qualitative research
methods is effective in exploring the meanings of social
phenomena experienced directly by the individual,
resulting in the collection of detailed, rich information
[17]. The findings suggest that gaining community ac-
ceptance and trust, as well as being selected from their
own communities, impact CDDs’ ability to reach house-
hold targets, as well as end users’ decision to ingest
medicines. In Cameroon and Uganda, CDD connected-
ness to the community was also emphasized among
study participants as a major deciding factor on whether
or not community members received CDDs and ac-
cepted the medicines [12, 18]. Additionally, CDDs that
are well-mannered, patient, effective communicators,
and knowledgeable are well received by the community
and perceived to perform well on the job [10]. In our
study, CDDs were not accepted or trusted due to poor
community awareness of MDA, cultural and religious
beliefs, and political propaganda. These findings are con-
sistent with those of Ames et al., 2019 and Ahorlu et al.,
2018 where community trust and selection of CDDs
Kusi et al. Infectious Diseases of Poverty            (2020) 9:22 Page 7 of 11
positively impacted treatment coverage [14, 19]. Partici-
pants also suggested that signs of appreciation from com-
munity members, such as provision of water and warm
reception encouraged CDDs, whereas encountering hos-
tile community members often discouraged them. An-
other relevant finding was around community distrust of
the government. Participants shared that they believe
MDA is the government’s attempt to promote family
planning. Odour has studied the integrity in public health
sector service delivery among the population in Busia
County, Kenya. Findings indicated that 68% of the respon-
dents were of the opinion that corruption in the public
health sector was a very serious problem. Respondents re-
ported corruption practices, such as harassment from
providers, extortion, absenteeism of providers and infor-
mal payments required for treatment [20]. Corrupt prac-
tices within the health system may fuel community
distrust of the NTD program, including CDDs.
The negative perception of MDA as a distribution
strategy among higher income individuals was another
interesting finding. These individuals feel that they have
no symptoms, and therefore, do not have a need to in-
gest medicines. They also do not find it appropriate to
ingest medicines provided by CDDs given that they have
access to private doctors and hospitals. However, indi-
viduals in the lower income classes embrace MDA. This
suggests that higher income individuals may associate
LF with poverty, do not trust the NTD program, and
have limited awareness of LF and the importance of
MDA. Lymphatic filariasis often affects the socially mar-
ginalized and poor due to lack of use or access to mos-
quito nets. In addition, morbidity and disability due to
LF significantly reduce economic output and increase
poverty [21]. The lack of education and awareness,
which may suggest a communication challenge with
CDDs, around MDA and LF has been well documented.
A study conducted by York et al., 2014 found that lack
of awareness and education around LF was observed in
both community members and CDDs [22]. The findings
also suggest that the timing of MDA affects CDDs’ abil-
ity to distribute drugs to community members and to
reach targets. Brieger 2000 found that community mem-
bers did not respect the volunteers’ time, approaching
them at any time of the day [23]. Furthermore, they were
often absent during distribution, requiring the volunteer
to visit again. This is because most people may be at
work or traveling. Chami and colleagues in Uganda have
documented CDD bias during MDA. They found that
CDDs were more likely to deliver drugs to individuals
who trusted them for health advice and were influential
in the community, which allows them to maintain their
own influential status [24]. This means that less privi-
leged individuals were less likely to be offered treatment.
Social bias from CDDs during MDA may also be due to
lack of sufficient monetary incentives, distance between
households, and limited resources. Finally, the role of
community leaders as informal supervisors that address
myths about MDA and support CDDs with drug distri-
bution serves as an important facilitator for achieving
MDA targets.
The findings of this study suggest that, even if med-
icines are available, community members may not
accept them because of distrust of the government,
poor interactions and communication with and be-
tween CDDs and communities, and lack of knowledge
and awareness of MDA and LF. Social bias from
CDDs and timing of MDA affect some individuals’
ability to access medicines during MDA. Medicines
must be located within reasonable reach of the people
who should benefit from it. CDDs must also have the
capacity, motivation, time and resources to distribute
medicines relation to the size of the target popula-
tion. In order for the NTD program in Kenya to
achieve epidemiologic coverage, the different dimen-
sions of effective coverage must be addressed. Table 2
below shows specific proposed solutions for improv-
ing MDA by theme and sub-theme. At the national
level, the NTD program can enact policies that ensure
that MDA is held at fixed posts, and in public spaces
to increase access to medicines for all individuals.
Furthermore, the roles of community elders can be
clearly defined to reflect supervision, positive
reinforcement and health education support during
MDA. This will ensure that all elders across commu-
nities help to improve MDA and support CDDs in a
uniform, systematic and impactful way. With a grow-
ing population and pressures to meet targets, CDDs
may be required to distribute medicines to communi-
ties that did not select them; however, the local NTD
program can actively work with community leaders to
recruit CDDs on an ongoing basis and place them on
standby. Pre-MDA activities at the national and local
levels can include digitally based messaging that as-
sures community members of integrity in the health
system, government and service providers. CDD mo-
tivation can be sustained through supportive supervi-
sion and adequate training, incentives and resources.
As concluded by Krentel and colleagues, implement-
ing and testing solutions for improving CDD motiv-
ation should be done so through the health system
for sustainability, and leverage novel approaches such
as digital technologies to effectively engage communi-
ties [15].
The current study highlights not only the barriers to the
successful implementation of MDA, but also the costs that
CDDs bear in order to meet NTD program demands. It
also highlights the importance of the careful choice of
CDDs in the fight against LF, as well as the need for more
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detailed research. Future studies can include comparisons
across CDDs in areas with high coverage and low cover-
age, and more in-depth exploration on CDDs’ job-related
experiences and their professional quality of life.
One of the main limitations of the study is the purpos-
ive selection of study participants by the sub-county
NTD program. In preparing for the study, we were ex-
pected to rely on the NTD program’s community health
Table 2 Solutions to improve MDA
Themes Sub-themes Solutions
Communication
between CDDs and
the community
CDDs hurriedly distribute drugs, resulting in little to no health
education.
• CDDs can be given an extra day for distribution or sensitization
in order to provide adequate health education for communities.
• CDD trainings can include modules that emphasize the
importance of and justification for providing health education to
households before administering medicines.
Qualities of good
CDDs
Trust is established between CDDs and communities when CDDs
are nominated and selected by their community.
CDDs that are perceived to behave well and have a good image
are desirable.
• Prior to the implementation of MDA, community leaders should
be provided with a roster that lists all CDDs assigned to their
community, and ensure that CDDs are known to and accepted
by the community. This can be done during standing
community meetings.
• CDD trainings can include modules on expectations of
community members for good behavior and image, and how to
achieve that.
Community resistance
toward CDDs
Community members’ distrust of CDDs often led to sharp
resistance and negative treatment of CDDs.
• Prior to MDA implementation, community leaders can hold a
meeting or forum introducing CDDs and explaining their roles.
During this meeting leaders can emphasize the importance of
accepting MDA and medicines
• Increase CDDs’ knowledge of LF through adequate training
before MDA
• Provide CDDs with the job resources, aids and time they need to
adequately conduct social mobilization activities before MDA
• Community leaders and key popular figures can show
community members that they have ingested medicines.
Community distrust of
the federal
government
Community members perceive that the government is motivated
by a political agenda, and that MDA is the platform used to
advance their harmful agenda.
• Government leaders at all levels can join community meetings
and record videos for various social media platforms to promote
MDA and the importance of ingesting medicines.
• Government leaders can collaborate with celebrities to use
digital media to build trust and assure the public that MDA and
medicines are safe and important.
CDD motivation Community members perceive that CDDs are motivated when
they feel appreciated by them.
• Communities can pool resources like water and food, and
provide it to CDDs during MDA.
• During meetings with community members, leaders can
encourage them to embrace CDDs, show them appreciation and
help them where they can
• The NTD program can ensure that program staff and supervisors
are always within walking distance of CDDs to reduce out of
pocket expenses on airtime and transport.
Perception of MDA as
a distribution strategy
Community members that perceive that drugs should be
distributed in private facilities or hospitals often don’t participate
in MDA and belong the higher income groups. On the other
hand, those in the lower income groups embrace MDA.
• The NTD program can offer those in higher income groups the
option of obtaining their medicines from health centers or their
own doctors.
Timing of MDA The period during which CDDs distributed medicines has an
impact on coverage.
• The NTD program can explore alternative dates for MDA, and
ensure that CDDs have adequate time and resources to conduct
mop-up.
• The NTD program can explore distribution of drugs in
workplaces, health centers and other fixed posts.
Community
accountability during
MDA
Community elders often help achieve treatment coverage
through indirect supervision of community members and CDDs
during MDA.
• Community leaders can serve as informal supervisors during
MDA by conducting random checks on households and CDDs.
CDD bias CDDs purposively decide which individuals and groups would
receive medicines, which impacts treatment coverage.
• CDD trainings can include modules that emphasize the negative
impact and consequences of overlooking certain individuals.
• Supervisors can closely monitor the progress of CDDs during
MDA, and ensure that daily targets are being met. Supervisor
trainings should include modules of effective and supportive
supervision of CDDs to reduce bias.
Community
understanding of CDD
job responsibilities
CDDs are expected to engage in a variety of activities before,
during and after MDA.
• CDD trainings should emphasize the importance of directly
observed treatment.
• Community meetings held prior to MDA should include
discussions around the responsibilities of CDDs.
CDDs Community drug distributors; LF Lymphatic filariasis; MDA Mass drug administration; NTDs Neglected tropical diseases.
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liaison to identify participants, which may have resulted
in a biased sample and respondents providing inter-
viewers with socially desirable responses. The study
could have been strengthened by conducting separate
focus groups for community members that did not par-
ticipate in the previous MDA and those that did.
Conclusions
The effective engagement of communities and CDDs in
the fight against LF is critical to the achievement of na-
tional and international elimination goals. Given the
introduction of new global targets and drug therapies,
there are added pressures on NTD programs to deliver
medicines to at-risk groups efficiently and effectively.
Additional treatment rounds along with its associated
enormous financial investments by donors may not be
sustainable, threatening the effectiveness of NTD pro-
grams to efficiently and effectively deliver treatment to
at-risk groups. In order to address these challenges,
changes at both the macro and micro levels must take
place. If the NTD programme in Kenya continues to
achieve low coverage, they will have to continue to treat
areas like Kaloleni and Mvita sub-counties, and possibly
experience delays in achieving WHO targets. This also
means that the country program will require additional
financial, human, and biomedical investments in order
to ensure that various stakeholders are effectively en-
gaged. If country NTD programs are going to be suc-
cessful in maximizing resources, sustaining the gains
made, and achieving elimination goals, it is imperative to
tackle MDA challenges at all levels of the health system.
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